发明名称 THERAPEUTIC COMPOUND FOR METABOLIC DISRUPTION
摘要 PROBLEM TO BE SOLVED: To provide a compound useful for treatment of various metabolic disruptions (for instance, insulin resistant syndrome, diabetes, hyperlipemia, fatty liver disease, cachexia, obesity, atherosclerosis, and arteriosclerosis).SOLUTION: This compound is a biologically active agent that is a compound or its pharmaceutically acceptable salt represented by the following formula 1 (wherein n is 1 or 2; m is 0 or 1; q is 0 or 1; t is 0 or 1; Ris hydrogen, halogen, or 1-3C alkoxy; X is -CH-, and Q is -OR, or X is -CHCRCR- or CHCH(NHAc)-, and Q is OR; or X is -CHCH-, and Q is NRR).
申请公布号 JP2013129665(A) 申请公布日期 2013.07.04
申请号 JP20130043951 申请日期 2013.03.06
申请人 WELLSTAT THERAPEUTICS CORP 发明人 SHARMA SHALINI;VON BORSTEL REID W;HODGE KIRVIN L;BAMAT MICHAEL K;WOLPE STEPHEN D
分类号 A61K31/00;A61K31/192;A61K31/16;A61K31/165;A61K31/198;A61K31/216;A61K31/235;A61K31/27;A61K31/381;A61K31/41;A61K31/4196;A61K31/4402;A61K31/445;A61K31/535;A61K31/54;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P5/50;A61P7/00;A61P9/10;A61P9/12;A61P13/12;A61P17/02;A61P25/00;A61P27/00;A61P27/12;A61P43/00;C07C59/54;C07C59/68;C07C59/90;C07C69/738;C07C217/22;C07C233/47;C07C235/34;C07C235/78;C07C235/84;C07C237/32;C07C259/06;C07C323/47;C07C323/52;C07C323/59;C07C323/60;C07D213/30;C07D213/55;C07D249/10;C07D249/12;C07D257/04;C07D333/16;C07D333/22 主分类号 A61K31/00
代理机构 代理人
主权项
地址